- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/13 - B-cells
Patent holdings for IPC class A61K 40/13
Total number of patents in this class: 69
10-year publication summary
|
0
|
1
|
1
|
2
|
3
|
9
|
1
|
3
|
20
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dana-Farber Cancer Institute, Inc. | 2668 |
5 |
| Regents of the University of Minnesota | 2794 |
3 |
| STEMCELL Technologies Canada Inc. | 302 |
3 |
| The University of North Carolina at Chapel Hill | 2111 |
3 |
| BE Biopharma, Inc. | 17 |
3 |
| Centre National de La Recherche Scientifique | 11055 |
2 |
| Children's National Medical Center | 281 |
2 |
| The Cleveland Clinic Foundation | 1581 |
2 |
| Institut Curie | 618 |
2 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3267 |
2 |
| Université Paris-saclay | 635 |
2 |
| Université Paris Cité | 918 |
2 |
| Fred Hutchinson Cancer Center | 478 |
2 |
| Arkea Bio Corp. | 19 |
2 |
| Novartis AG | 10178 |
1 |
| Massachusetts Institute of Technology | 10273 |
1 |
| Board of Regents, The University of Texas System | 6135 |
1 |
| Tsinghua University | 6224 |
1 |
| University of Florida Research Foundation, Inc. | 4184 |
1 |
| Northwestern University | 3554 |
1 |
| Other owners | 28 |